Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00856778 · ClinicalTrials.gov registry record · NA

Virtue® Male Incontinence Sling Study

A NA study of Stress Urinary Incontinence, sponsored by Coloplast A/S.

Completed
Registry status
NA
Development phase
98
Enrollment target
11
Study locations

NCT00856778 is a NA study of Stress Urinary Incontinence that has completed, run by Coloplast A/S. The registered enrollment target is 98 participants, below the 160-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (39% lower). The trial reports 11 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00856778, a NA study of Stress Urinary Incontinence, has completed, sponsored by Coloplast A/S.

COMPLETED
Registry status
NA
Development phase
98 participants
Enrollment target
11
Study locations

Study Summary

This study is a multi-center, global study that will assess the effectiveness and patient satisfaction of the male incontinence sling 12 months after implant as well as the safety profile of the product.

Interventions

  • DEVICE Virtue® Male Incontinence Sling

Study Locations (11)

California

  • Kaiser Permanente - Los Angeles
  • Stanford University Medical Center - Stanford

Quebec

  • Mortimer S Davis Jewish General Hospital - Montreal
  • CHUS Hopital Fleurimont - Sherbrooke

Florida

  • Winter Park Urology Associates - Orlando

Indiana

  • Northeast Indiana Research - Fort Wayne

Michigan

  • Wayne State University - Dearborn

New York

  • NYU Urology Associates - New York

North Carolina

  • McKay Urology - Charlotte

Texas

  • University of Texas-M.D. Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2009-01
Est. Completion 2011-01
Phase NA

Sponsor

Coloplast A/S

21 total trials

What the Registry Record Tells You About NCT00856778

The ClinicalTrials.gov registry entry for NCT00856778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (39% lower). The listed sponsor is Coloplast A/S, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Virtue® Male Incontinence Sling is the first listed.

NCT00856778 reports 11 study locations spanning 9 distinct geographic areas - top geographies include California, Quebec, Florida.

Frequently Asked Questions

What is clinical trial NCT00856778 about?

NCT00856778 is a clinical study titled "Virtue® Male Incontinence Sling Study". This study is a multi-center, global study that will assess the effectiveness and patient satisfaction of the male incontinence sling 12 months after implant as well as the safety profile of the product.

What is the current status of trial NCT00856778?

This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2009-01. Estimated completion is 2011-01.

What conditions does trial NCT00856778 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence.

What interventions are being tested in trial NCT00856778?

The interventions under investigation include: Virtue® Male Incontinence Sling (DEVICE).

Who is sponsoring clinical trial NCT00856778?

This trial is sponsored by Coloplast A/S, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00856778 being conducted?

This trial has 11 study locations across California, Florida, Indiana, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.